SGC

Business Context and Reporting Period

Company: Superior Group of Companies, Inc. (SGC)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2026
Business Overview: The Company operates three segments: Branded Products (promotional products/uniforms), Healthcare Apparel (scrubs/medical apparel), and Contact Centers (business process outsourcing). The Company is an accelerated filer and a smaller reporting company.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 2.6% ($3.8 million) for the quarter and 2.7% ($7.6 million) for the six months compared to the prior year periods. Growth was driven by the Branded Products segment (+6.2% QoQ, +5.7% 6mo), partially offset by declines in Healthcare Apparel and Contact Centers.
• Profitability: Net income decreased 21.3% for the quarter ($1.2M vs $1.6M) due to a $2.6 million tradename impairment charge in the Healthcare Apparel segment. However, net income increased 159.1% for the six months ($2.1M vs $0.8M) due to segment growth and lower interest expense.
• Impairment Charge: A non-cash impairment charge of $2.6 million was recorded in Q2 2026 related to the CID Resources trade name within the Healthcare Apparel segment, reducing carrying value to estimated fair value.
• Interest Expense: Net interest expense decreased 21.5% for the quarter and 24.1% for the six months, driven by a lower weighted average interest rate (4.8% vs 5.6% in prior year).
• Cash Flow: Operating cash flow for the six months ended June 30, 2026, was $17.7 million, a significant increase from $2.9 million in the prior year period, driven by improved collections and reduced inventory purchasing.

Guidance, Outlook, Risks, and Unusual Items

• Tariff and Trade Environment: The Company recorded a $4.3 million tariff refund (reducing COGS) following a Supreme Court ruling invalidating certain IEEPA tariffs. New tariffs under Section 122 and Section 301 of the Trade Act of 1974 were implemented in July 2026. Trade agreements (AGOA, HOPE, HELP) were retroactively extended to December 2026; failure to renew could negatively impact costs.
• Segment Performance: The Contact Centers segment faced client attrition exceeding new acquisitions. The Healthcare Apparel segment saw margin pressure from inventory write-downs, partially offset by tariff refunds.
• Liquidity and Capital: The Company maintains a $125 million revolving credit facility and a $75 million term loan (maturing August 2027). As of June 30, 2026, $26 million was drawn on the revolver. The Company is in compliance with debt covenants (fixed charge coverage and net leverage ratios).
• Shareholder Returns: The Company paid $4.4 million in dividends for the six months ended June 30, 2026. A 10b5-1 trading plan was entered into in March 2026 to repurchase up to $2.5 million of stock under a broader $17.5 million program.
• Risks: Key risks include global conflicts (Russia-Ukraine, Middle East), supply chain disruptions, inflation, labor shortages, and the impact of changing trade policies and tariffs.

Investor Verification Checklist

• Impairment Details: Verify the assumptions used in the $2.6 million CID Resources impairment test (royalty rates, growth rates, discount rates) and the sustainability of the Healthcare Apparel segment's profitability.
• Tariff Exposure: Assess the impact of new tariffs implemented in July 2026 and the status of trade agreement renewals post-December 2026 on future margins.
• Contact Centers Attrition: Review the rate of client attrition in the Contact Centers segment and the effectiveness of new customer acquisition strategies.
• Debt Covenants: Confirm continued compliance with the fixed charge coverage ratio (1.25:1) and net leverage ratio (4.0:1) given the current interest rate environment.
• Inventory Levels: Monitor inventory write-downs and the $90.5 million inventory balance relative to sales velocity, particularly in the Healthcare Apparel segment.